ViAqua Therapeutics Ltd.

ViAqua Therapeutics Ltd. is dedicated to providing innovative and cost-effective health management solutions for the aquaculture industry. Specializing in biotechnology research, ViAqua Therapeutics is committed to enhancing aquaculture practices through cutting-edge technologies.

ViAqua Therapeutics' primary focus is on developing an oral delivery platform designed to administer RNA. This groundbreaking approach is being co-developed with Skretting, a Nutreco company, to create RNA-induced resistance to White Spot Shrimp Virus. This innovative solution is seamlessly integrated into and delivered via shrimp feed, ensuring ease of use and maximum effectiveness.

Located in Haifa, IL, ViAqua Therapeutics is positioned at the forefront of aquaculture health enhancement. We invite the management of ViAqua Therapeutics Ltd. to further enrich this description with a customized and exclusive company showcase and product listing on our platform, highlighting the unique value and potential of ViAqua's contributions to the aquaculture industry.